Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2024-03-27

Clinical Trial Update: Chlorhexidine Scrub, ZnO Nanoparticles Socks and the Combination for Prevention of Pitted Keratolysis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating chlorhexidine scrub, ZnO nanoparticles socks, and their combination for prevention of foot dermatoses has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine Scrub (chlorhexidine)
  • ZnO Nanoparticles Socks (zinc oxide nanoparticles socks)

Snippet

Sponsor: Mahidol University | Conditions: Foot Dermatoses | Phase 4 | Status: WITHDRAWN